McKesson

NYSE: MCK
$339.87
-$2.13 (-0.6%)
Closing price September 30, 2022
Wednesday's top analyst upgrades and downgrades included Altria, Apple, Bath & Body Works, BorgWarner, Chevron, Exxon Mobil, FedEx, Occidental Petroleum, Peabody Energy, Plug Power, Rio Tinto,...
Monday's top analyst upgrades and downgrades included Bill.com, Cigna, ConocoPhillips, Estee Lauder, Fortinet, Microchip Technology, Pfizer, Skyworks Solutions, Snap, Snowflake, VICI Properties and...
Monday's top analyst upgrades and downgrades included Airbnb, AT&T, Duke Energy, Etsy, FirstEnergy, Gap, IBM, KeyCorp, Kohl's, Las Vegas Sands, Nvidia, Starbucks, Trade Desk and Visa.
In a move that investors looking for more defensive ideas should applaud, the analysts at Goldman Sachs have added Bristol-Myers Squibb to the Americas Conviction List. Plus, here are four additional...
Monday's top analyst upgrades and downgrades included AbbVie, Alibaba, Archer Daniels Midland, Best Buy, Intel, Nikola, Peloton Interactive, SAP, Under Armour and Wynn Resorts.
Tuesday's top analyst upgrades and downgrades included Charter Communications, Clorox, FirstEnergy, Neurocrine Biosciences, RingCentral, Roku, Seagate Technology, Take-Two Interactive Software and...
The Goldman Sachs analysts feel these five companies could see direct benefits from the movement of supply chains and manufacturing out of Asia, specifically China.
Many hospitals shut down elective surgeries and other activities to brace for the impact of COVID-19. However, analysis on these shutdowns is yielding some interesting insight.
These four blue chip large-cap stocks have taken a beating this year and all offer patient investors the potential for some big upside.
Johnson & Johnson is trading higher on the news, but some smaller public companies tied into the opioid crisis are taking it on the chin.
Stocks were looking for a higher open on Tuesday, with this day being a shortened one ahead of the July 4th holiday. The prior trend of buying the dips has not worked as well in recent months as it...
Amazon's announced acquisition of pharmacy firm PillPack has sent a shockwave through retail pharmacy stocks, pharmacy benefits management companies, and drug distribution firms. And the deal isn't...
These eight top companies in various sectors are expected to beat earnings estimates, are under-owned by fund managers and are rated Buy at Merrill Lynch.
The top analyst upgrades, downgrades and other research calls from Monday include Blue Apron, Broadcom, Charter Communications, CVS Health, Delphi, eBay, Rite Aid and UPS.
The top analyst upgrades, downgrades and other research calls from Thursday include Apache, Apple, Berkshire Hathaway, eBay, GrubHub, Hess, Nike, Nucor and Wayfair.